More importantly, upregulated Runx2 expression is found in the HSC during the development of NAFLD in a mouse model,8 and Runx2 increases tissue inhibitor of metalloproteinase‐1 (TIMP‐1) expression by binding to its promoter in the activated HSC of rats.19 This evidence concerns the gene RUNX2 and metabolic dysfunction-associated steatotic liver disease.